Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis
NCT05105347
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
130
Enrollment
OTHER
Sponsor class
Conditions
Uveitis
Interventions
DRUG:
Adalimumab plus different doses of oral glucocorticosteroid
Sponsor
Peking Union Medical College Hospital